January 3, 2012 – Novadaq Technologies Inc., a developer of real-time imaging systems for use in the operating room, and Maquet Cardiovascular, a manufacturer of products for cardiac surgery, vascular intervention and cardiac support, announced that the companies have signed an agreement naming Maquet Cardiovascular as the exclusive distributor of Novadaq's CO2 Heart Laser systems and procedure kits in the United States.
The CO2 Heart Laser System for transmyocardial revascularization (TMR) is indicated for use in patients suffering from severe angina that is not amenable to traditional medical or coronary revascularization therapies. During the TMR procedure, the CO2 Heart Laser creates small channels in the heart tissue, which stimulate improvements in blood flow to regions of the heart.
"This distribution agreement with Novadaq for the CO2 Heart Laser fits well into Maquet 's current portfolio of cardiac surgery products and allows us to provide our customers additional therapies to meet their patients' needs," said Raoul Quintero, president, U.S. Sales and Service Organization, Maquet Medical Systems.
"The alliance with Maquet represents Novadaq's fourth commercial agreement with a market leader," said Arun Menawat, M.D., president and CEO, Novadaq.
For more information: www.maquet.com, www.novadaq.com
March 25, 2026 
